Big Pharma Howls As Feds Eye Wider Drug Negotiations
Federal regulators on Monday floated a politically sensitive plan to expand Medicare's power to negotiate drug discounts, prompting immediate outcry from the pharmaceutical lobby....To view the full article, register now.
Already a subscriber? Click here to view full article